This federal contract award is for the delivery of Ozempic® (semaglutide) 0.25-0.5 mg/dose pens to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $32,717.28 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on December 5, 2024, with a completion date of December 6, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Generated 3/6/25, 9:49 AM